glp-1 drugs and pancreatitis RAs: Safe, Effective, Possibly Protective in Acute | Kshitij Thakur MD, MSc posted on the topic The GLP-1 Agonists and Obesity:

Ozempic and Mounjaro are covered for type 2 diabetes with PA on virtually every UHC commercial plan

Appetite suppression becomes more noticeable, particularly around meal times

Encapsulation of exenatide in poly-(d,l-lactide- co -glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes

Bottom line: GLP-1 patches may contain recognisable ingredients, but there is currently no strong evidence that those ingredients are absorbed through the skin in amounts sufficient to support the effects claimed

[13] American College of Cardiology

Beavers KM, Neiberg RH, Johnson KC, Davis CH, Casanova R, Schwartz AV, et al